Cardiovascular Risks and Outcome in COVID-19 Positive Patients With Cardiovascular Disease Attending Primary Health Care Corporation in Qatar: A Retrospective Cohort Study

<h3>Background </h3><p dir="ltr">Coronavirus disease (COVID-19) patients with cardiovascular disease (CVD) are at a higher risk of morbidity and mortality. This study describes the risks and outcome in COVID-19 patients with CVD attending Primary Health Care Corporation (PHCC) settings in Qatar. </p><h3>Objective</h3><p dir="ltr">To report whether CVD increases the risk for hospitalization and further complications in COVID-19 patients. </p><h3>Methods</h3><p dir="ltr">Retrospective cohort study. </p><h3>Results</h3><p dir="ltr">A total of 10,178 CVD patients’ data who tested positive for COVID-19 were extracted from <u>electronic medical records</u> on the basis of inclusion criteria and analyzed during the period of February 1, 2020 to December 31, 2020 (11 months). Among the patients included in the study, 64% (n=6527) were men and 36% (n=3651) were women; 23% (n=2299) were Qataris and 77% (n=7879) were non-Qataris. Among the selected age group of greater than 25 to less than 75 years, the median age was 50.83 years. More than half of the patients had diabetes (69.6%; n=7086) followed by hypertension (68.4%; n=6965) and <u>dyslipidemia</u> (45.1%; n=4590). Other comorbidities were obesity (18.3%; n=1862), <u>kidney disease</u> (6.5%; n=659), hematologic problems (4.2%; n=425), liver disorders (1.4%; n=142), <u>rheumatic heart disease</u> (1.3%; n=131) and <u>neurologic symptoms</u> (1.3%; n=128). <u>Multivariate analysis</u> for factors associated with inpatient admissions in last 28 days for patients with CVD reported that patients with age greater than 70 years are 2.8 (1.86-4.18) times higher risk of hospital admission as compared with the patients 25-30 years of age. </p><h3>Conclusion</h3><p dir="ltr">The pre-existing CVD with age and other comorbidities predict the risk for hospitalization and further complications in patients with COVID-19. Further studies are needed to investigate the data from primary and secondary care about the long-term cardiovascular outcomes of patients who have survived COVID-19.</p><h2>Other Information</h2><p dir="ltr">Published in: Mayo Clinic Proceedings: Innovations, Quality & Outcomes<br>License: <a href="http://creativecommons.org/licenses/by-nc-nd/4.0/" target="_blank">http://creativecommons.org/licenses/by-nc-nd/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.mayocpiqo.2022.08.001" target="_blank">https://dx.doi.org/10.1016/j.mayocpiqo.2022.08.001</a></p>